Tasmanian Botanics
Cultivation & AU-GMP Manufacturing
ABN 27 845 110 293
Brighton, TAS 7030
(03) 6212 4400 · enquiries@tasmanianbotanics.com.au
Certificate of Analysis
QC-26-1171
Product
TB Oil CBD 100 · 30 mL
Item code
TB-OIL-C100-30
Lot number
L26-0496
Cultivar
Tassie Midlands
Genetics
In-house Tasmanian selection
Batch size
13.1 kg · 437 packs
Manufacturing run
MB-26-0395
Source harvest
HB-26-102
Crop batch
CB-26-0283
Date of manufacture
19 Jun 2026
Expiry
19 Dec 2027
Testing laboratory
Symbio Laboratories
| Analyte | Method | Specification | Result | Outcome |
|---|---|---|---|---|
| Total THC | HPLC-DAD | 19% ± 20% | 0.4% | Pass |
| Total CBD | HPLC-DAD | Reported | 10.1% | Pass |
| Water activity | AOAC 978.18 | ≤ 0.65 aᵥ | Pending | Pending |
| Total yeast & mould | TGO 93 · plate count | ≤ 1.0 × 10⁵ CFU/g | 40 CFU/g | Pass |
| E. coli | TGO 93 | Absent / g | Absent | Pass |
| Salmonella spp. | TGO 93 | Absent / 10 g | Absent | Pass |
| Heavy metals (As, Cd, Pb, Hg) | ICP-MS | TGO 93 limits | Pass | Pass |
| Pesticides (400-analyte panel) | LC-MS/MS · GC-MS/MS | TGO 93 limits | Pass | Pass |
| Foreign matter | Visual | ≤ 2% w/w | Complies | Pass |
Disposition
Released
This lot meets the finished-product specification in full and is released for supply.
Certified by
Fiona Ballard
Quality Manager & Authorised Person
23 Jun 2026
Signature
Issued under TGA manufacturing licence MI-2024-LI-02318-1 and ODC manufacture licence ML-0112. Tested against Therapeutic Goods Order No. 93, the Standard for Medicinal Cannabis. Generated by the Tasmanian Botanics operations platform on 28 Jul 2026.